No Data
Fangzhou Widens Loss in 2024
Express News | Fangzhou Inc. Reports Strong Growth in 2024 Annual Results: 11.2% Revenue Growth and 139% Year-on-Year Increase in Adjusted Net Profit Driven by AI-Powered Innovation
Press Release: Fangzhou Inc. Reports Strong Growth in 2024 Annual Results: 11.2% Revenue Growth and 139% Year-on-Year Increase in Adjusted Net Profit Driven by AI-Powered Innovation
Ark Health's stock price rose over 8%. The revenue for 2024 is 2.707 billion yuan, an increase of 11.2% year-on-year.
Ark Health (06086) saw its stock price rise by 8.67% after the earnings report, currently at HK$5.89, with a trading volume of HK$13.1188 million. On March 23, Ark Health (06086) released its performance announcement for the year ending December 31, 2024. In 2024, the company's revenue is expected to grow by 11.2% compared to 2023, reaching 2.707 billion yuan, mainly benefiting from increases in revenue from offline retail pharmacy services, wholesale, and customized content and marketing solutions.
Revenues Tell The Story For Fangzhou Inc. (HKG:6086) As Its Stock Soars 32%
Ark Health (06086.HK) achieved revenue of over 2.7 billion yuan for the fiscal year 2024, with adjusted net profit significantly increasing by 139%.
On March 21, the company announced its annual performance, reporting revenue of 2.707 billion yuan for the year ending December 31, 2024, an increase of 11.22% year-on-year; the adjusted net profit for 2024 is expected to grow significantly by 139% compared to 2023, benefiting from continuous technological enhancements and improved Operation efficiency. During the reporting period, the platform experienced strong growth, with increased user engagement. As of December 31, 2024, the platform's registered users rose to 49.2 million. For the twelve months ending December 31, 2024, the average monthly active users reached.
